$2.45
-0.02[-0.81%]
At close: Apr 18
$2.45
0[0.00%]
After Hours: 5:24PM EDT
Minerva Neurosciences
(NASDAQ:NERV)Minerva Neurosciences Stock (NASDAQ:NERV), Analyst Ratings, Price Targets, Predictions
Minerva Neurosciences Inc has a consensus price target of $5.5, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on February 27, 2024, August 2, 2023, and May 16, 2023. With an average price target of $10 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 308.16% upside for Minerva Neurosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JMP Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Minerva Neurosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2024 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 348.98% | HC Wainwright & Co. | Douglas Tsao | → $11 | Reiterates | Neutral → Neutral | Get Alert |
| 08/02/2023 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 348.98% | HC Wainwright & Co. | Douglas Tsao | $8 → $11 | Maintains | Neutral | Get Alert |
| 05/16/2023 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 226.53% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | Neutral → Neutral | Get Alert |
| 05/02/2023 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 226.53% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | → Neutral | Get Alert |
| 03/09/2023 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 226.53% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | → Neutral | Get Alert |
| 11/10/2022 | NERV | Buy Now | Minerva Neurosciences | $2.45 | — | HC Wainwright & Co. | Douglas Tsao | — | Downgrade | Buy → Neutral | Get Alert |
| 10/17/2022 | NERV | Buy Now | Minerva Neurosciences | $2.45 | — | JMP Securities | Jason Butler | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 03/04/2022 | NERV | Buy Now | Minerva Neurosciences | $2.45 | 104.08% | HC Wainwright & Co. | Douglas Tsao | $80 → $40 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Minerva Neurosciences (NERV)?
The latest price target for Minerva Neurosciences (NASDAQ: NERV) was reported by HC Wainwright & Co. on February 27, 2024. The analyst firm set a price target for $11.00 expecting NERV to rise to within 12 months (a possible 348.98% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Minerva Neurosciences (NERV)?
The latest analyst rating for Minerva Neurosciences (NASDAQ: NERV) was provided by HC Wainwright & Co., and Minerva Neurosciences reiterated their neutral rating.
When was the last upgrade for Minerva Neurosciences (NERV)?
There is no last upgrade for Minerva Neurosciences.
When was the last downgrade for Minerva Neurosciences (NERV)?
The last downgrade for Minerva Neurosciences Inc happened on November 10, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Minerva Neurosciences Inc.
When is the next analyst rating going to be posted or updated for Minerva Neurosciences (NERV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Minerva Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Minerva Neurosciences was filed on February 27, 2024 so you should expect the next rating to be made available sometime around February 27, 2025.
Is the Analyst Rating Minerva Neurosciences (NERV) correct?
While ratings are subjective and will change, the latest Minerva Neurosciences (NERV) rating was a reiterated with a price target of $0.00 to $11.00. The current price Minerva Neurosciences (NERV) is trading at is $2.45, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.